1 May 2024 true Taxfiler 2024.6 10127895 business:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 10127895 2024-04-30 10127895 business:EntityNoLongerTradingButTradedInPast 2024-05-01 2025-04-30 10127895 2024-05-01 2025-04-30 10127895 business:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 10127895 business:FilletedAccounts 2024-05-01 2025-04-30 10127895 2025-04-30 10127895 business:Director1 2024-05-01 2025-04-30 10127895 business:RegisteredOffice 2024-05-01 2025-04-30 10127895 2024-04-30 10127895 core:ShareCapital core:PreviouslyStatedAmount 2025-04-30 10127895 core:ShareCapital core:PreviouslyStatedAmount 2024-04-30 10127895 core:PreviouslyStatedAmount 2025-04-30 10127895 core:PreviouslyStatedAmount 2024-04-30 10127895 business:SmallEntities 2024-05-01 2025-04-30 10127895 countries:EnglandWales 2024-05-01 2025-04-30 10127895 2023-05-01 2024-04-30 iso4217:GBP xbrli:pure
Company Registration No. 10127895 (England and Wales)
IQ PHARMATECH LIMITED Unaudited accounts for the year ended 30 April 2025
IQ PHARMATECH LIMITED Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
IQ PHARMATECH LIMITED Company Information for the year ended 30 April 2025
Director
Mohammad Mokhlis Abdullatif
Company Number
10127895 (England and Wales)
Registered Office
125 WOOD STREET LONDON EC2V 7AW UNITED KINGDOM
Accountants
KM Accountancy Services Ltd 1000 Great West Rd United Business Centre Brentford, London TW8 9DW
- 3 -
IQ PHARMATECH LIMITED Statement of financial position as at 30 April 2025
2025
2024
Notes
£
£
Called up share capital not paid
1
1
Net current assets
-
-
Net assets
1
1
Capital and reserves
Called up share capital
1
1
Shareholders' funds
1
1
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 6 January 2026 and were signed on its behalf by
Mohammad Mokhlis Abdullatif Director Company Registration No. 10127895
- 4 -
IQ PHARMATECH LIMITED Notes to the Accounts for the year ended 30 April 2025
1
Statutory information
IQ PHARMATECH LIMITED is a private company, limited by shares, registered in England and Wales, registration number 10127895. The registered office is 125 WOOD STREET, LONDON, EC2V 7AW, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 5 -